Data of intracellular insulin protein reduced by autophagy in INS-1E cells

Hansung Kim, Yeong Min Yoo

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Autophagy appears to be involved in maintaining normal intracellular insulin content by accelerating the insulin degradation rate in β-cells (Marsh et al., 2007) [1]. 2-deoxy-d-glucose (2-DG) is metabolized by hexokinase, and acts as an inhibitor of glycolysis. 2-DG triggers glucose deprivation without altering other nutrients or metabolic pathways (Aghaee et al., 2012) [2], and appears to be an ideal tool for studying autophagy. Rapamycin induced upregulation of autophagy in both cultured isolated islets and pancreatic β-cells (Tanemura et al., 2012) [3]. Here, we examined that 2-DG or rapamycin-induced autophagy may decrease the production of intracellular insulin in INS-1E insulinoma cells. Data showed that autophagy was increased by 2-DG or rapamycin by Western blotting and Immunofluorescence staining analyses. Also, intracellular insulin decreased by 2-DG or rapamycin. Furthermore, the autophagy inhibitors, bafilomycin A1 and/or 3-methyladenine, in the presence or absence of 2-DG or rapamycin increased intracellular insulin in INS-1E insulinoma cells.

Original languageEnglish
Pages (from-to)1151-1156
Number of pages6
JournalData in Brief
Volume8
DOIs
Publication statusPublished - 2016 Sep 1

Fingerprint

Autophagy
Sirolimus
Insulin
Glucose
Proteins
Insulinoma
Hexokinase
Glycolysis
Metabolic Networks and Pathways
Islets of Langerhans
Fluorescent Antibody Technique
Up-Regulation
Western Blotting
Staining and Labeling
Food

All Science Journal Classification (ASJC) codes

  • General

Cite this

@article{95b8353a68494e7a8e0f447a06660e65,
title = "Data of intracellular insulin protein reduced by autophagy in INS-1E cells",
abstract = "Autophagy appears to be involved in maintaining normal intracellular insulin content by accelerating the insulin degradation rate in β-cells (Marsh et al., 2007) [1]. 2-deoxy-d-glucose (2-DG) is metabolized by hexokinase, and acts as an inhibitor of glycolysis. 2-DG triggers glucose deprivation without altering other nutrients or metabolic pathways (Aghaee et al., 2012) [2], and appears to be an ideal tool for studying autophagy. Rapamycin induced upregulation of autophagy in both cultured isolated islets and pancreatic β-cells (Tanemura et al., 2012) [3]. Here, we examined that 2-DG or rapamycin-induced autophagy may decrease the production of intracellular insulin in INS-1E insulinoma cells. Data showed that autophagy was increased by 2-DG or rapamycin by Western blotting and Immunofluorescence staining analyses. Also, intracellular insulin decreased by 2-DG or rapamycin. Furthermore, the autophagy inhibitors, bafilomycin A1 and/or 3-methyladenine, in the presence or absence of 2-DG or rapamycin increased intracellular insulin in INS-1E insulinoma cells.",
author = "Hansung Kim and Yoo, {Yeong Min}",
year = "2016",
month = "9",
day = "1",
doi = "10.1016/j.dib.2016.07.008",
language = "English",
volume = "8",
pages = "1151--1156",
journal = "Data in Brief",
issn = "2352-3409",
publisher = "Elsevier BV",

}

Data of intracellular insulin protein reduced by autophagy in INS-1E cells. / Kim, Hansung; Yoo, Yeong Min.

In: Data in Brief, Vol. 8, 01.09.2016, p. 1151-1156.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Data of intracellular insulin protein reduced by autophagy in INS-1E cells

AU - Kim, Hansung

AU - Yoo, Yeong Min

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Autophagy appears to be involved in maintaining normal intracellular insulin content by accelerating the insulin degradation rate in β-cells (Marsh et al., 2007) [1]. 2-deoxy-d-glucose (2-DG) is metabolized by hexokinase, and acts as an inhibitor of glycolysis. 2-DG triggers glucose deprivation without altering other nutrients or metabolic pathways (Aghaee et al., 2012) [2], and appears to be an ideal tool for studying autophagy. Rapamycin induced upregulation of autophagy in both cultured isolated islets and pancreatic β-cells (Tanemura et al., 2012) [3]. Here, we examined that 2-DG or rapamycin-induced autophagy may decrease the production of intracellular insulin in INS-1E insulinoma cells. Data showed that autophagy was increased by 2-DG or rapamycin by Western blotting and Immunofluorescence staining analyses. Also, intracellular insulin decreased by 2-DG or rapamycin. Furthermore, the autophagy inhibitors, bafilomycin A1 and/or 3-methyladenine, in the presence or absence of 2-DG or rapamycin increased intracellular insulin in INS-1E insulinoma cells.

AB - Autophagy appears to be involved in maintaining normal intracellular insulin content by accelerating the insulin degradation rate in β-cells (Marsh et al., 2007) [1]. 2-deoxy-d-glucose (2-DG) is metabolized by hexokinase, and acts as an inhibitor of glycolysis. 2-DG triggers glucose deprivation without altering other nutrients or metabolic pathways (Aghaee et al., 2012) [2], and appears to be an ideal tool for studying autophagy. Rapamycin induced upregulation of autophagy in both cultured isolated islets and pancreatic β-cells (Tanemura et al., 2012) [3]. Here, we examined that 2-DG or rapamycin-induced autophagy may decrease the production of intracellular insulin in INS-1E insulinoma cells. Data showed that autophagy was increased by 2-DG or rapamycin by Western blotting and Immunofluorescence staining analyses. Also, intracellular insulin decreased by 2-DG or rapamycin. Furthermore, the autophagy inhibitors, bafilomycin A1 and/or 3-methyladenine, in the presence or absence of 2-DG or rapamycin increased intracellular insulin in INS-1E insulinoma cells.

UR - http://www.scopus.com/inward/record.url?scp=85022014146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022014146&partnerID=8YFLogxK

U2 - 10.1016/j.dib.2016.07.008

DO - 10.1016/j.dib.2016.07.008

M3 - Article

VL - 8

SP - 1151

EP - 1156

JO - Data in Brief

JF - Data in Brief

SN - 2352-3409

ER -